HistoSonics, a Minneapolis based medical technology company, is developing a novel non-invasive platform and new sonic beam therapy utilizing the science of histotripsy, a novel mechanism of action that uses focused acoustic energy to mechanically destroy and liquify targeted tissues at the cellular level with precision and control.